Article
Polymorphisms of the kappa opioid receptor and prodynorphin genes: HIV risk and HIV natural history.
Journal of acquired immune deficiency syndromes (1999) - 1 May 2013
Proudnikov Dmitri, Randesi Matthew, Levran Orna, Yuferov Vadim, Crystal Howard, Ho Ann, Ott Jurg, Kreek Mary J
Abstract excerpt
OBJECTIVE: Studies indicate cross-desensitization between opioid receptors (eg, kappa opioid receptor, OPRK1) and chemokine receptors (eg, CXCR4) involved in HIV infection. Whether gene variants of OPRK1 and its ligand, prodynorphin (PDYN), influence the outcome of HIV therapy was tested. METHODS: Three study points, admission to the Women's Interagency HIV Study, initiation of highly active antiretroviral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
